- Report
- October 2023
- 183 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- July 2024
- 80 Pages
United Kingdom
From €4323EUR$4,750USD£3,672GBP
- Report
- February 2024
- 130 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- February 2024
- 80 Pages
India
From €4323EUR$4,750USD£3,672GBP
- Report
- April 2023
- 110 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- April 2023
- 120 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- January 2022
- 111 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- January 2022
- 122 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- July 2021
- 111 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- May 2022
- 163 Pages
Global
From €3277EUR$3,600USD£2,783GBP
- Report
- May 2022
- 80 Pages
Europe
From €1365EUR$1,500USD£1,160GBP
- Report
- January 2025
- 25 Pages
Singapore
From €995EUR$1,171USD£875GBP
- Report
- January 2025
- 109 Pages
Singapore
From €2675EUR$3,148USD£2,352GBP
- Report
- October 2024
- 101 Pages
Turkey
From €2675EUR$3,148USD£2,352GBP
- Report
- October 2024
- 23 Pages
Turkey
From €995EUR$1,171USD£875GBP
- Report
- October 2024
- 25 Pages
Slovakia
From €995EUR$1,171USD£875GBP
- Report
- October 2024
- 25 Pages
Peru
From €995EUR$1,171USD£875GBP
- Report
- September 2024
- 114 Pages
Belgium
From €2675EUR$3,148USD£2,352GBP
- Report
- September 2024
- 116 Pages
Mexico
From €2675EUR$3,148USD£2,352GBP
- Report
- September 2024
- 28 Pages
Belgium
From €995EUR$1,171USD£875GBP

The Over the Counter (OTC) Analgesics market is a segment of the OTC Drugs industry that focuses on providing relief from pain and discomfort. These products are available without a prescription and are typically used to treat mild to moderate pain. Common OTC analgesics include acetaminophen, ibuprofen, and aspirin. These products are available in a variety of forms, such as tablets, capsules, liquids, and topical creams.
The OTC Analgesics market is highly competitive, with a wide range of products available from both large and small companies. Major players in the market include Bayer, Pfizer, Johnson & Johnson, GlaxoSmithKline, and Novartis. Other companies in the market include Perrigo, Prestige Brands, and Sun Pharmaceuticals. Show Less Read more